1. Balla, András, Hunyady, László. . Nephrogenic Diabetes Insipidus. In Experientia supplementum (2012), 111, 317-339. doi:10.1007/978-3-030-25905-1_15. https://pubmed.ncbi.nlm.nih.gov/31588538/
2. Li, Mengwei, Liu, Guangxiang, Jin, Xinrong, Lin, Yunfei, Xu, Hanmei. 2022. Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma. In Molecular cancer, 21, 181. doi:10.1186/s12943-022-01654-1. https://pubmed.ncbi.nlm.nih.gov/36117171/
3. Kikuchi, Hiroaki, Jung, Hyun Jun, Raghuram, Viswanathan, Chen, Lihe, Knepper, Mark A. 2021. Bayesian identification of candidate transcription factors for the regulation of Aqp2 gene expression. In American journal of physiology. Renal physiology, 321, F389-F401. doi:10.1152/ajprenal.00204.2021. https://pubmed.ncbi.nlm.nih.gov/34308668/
4. Bichet, D G. . Nephrogenic diabetes insipidus. In The American journal of medicine, 105, 431-42. doi:. https://pubmed.ncbi.nlm.nih.gov/9831428/
5. Bichet, Daniel G. . Nephrogenic diabetes insipidus. In Advances in chronic kidney disease, 13, 96-104. doi:. https://pubmed.ncbi.nlm.nih.gov/16580609/
6. Morello, J P, Bichet, D G. . Nephrogenic diabetes insipidus. In Annual review of physiology, 63, 607-30. doi:. https://pubmed.ncbi.nlm.nih.gov/11181969/